Environmental Exposure during Pregnancy: Influence on Prenatal Development and Early Life: A Comprehensive Review.


Journal

Fetal diagnosis and therapy
ISSN: 1421-9964
Titre abrégé: Fetal Diagn Ther
Pays: Switzerland
ID NLM: 9107463

Informations de publication

Date de publication:
2021
Historique:
received: 05 05 2020
accepted: 31 01 2021
pubmed: 19 3 2021
medline: 25 11 2021
entrez: 18 3 2021
Statut: ppublish

Résumé

Preconception and prenatal exposure to environmental contaminants may affect future health. Pregnancy and early life are critical sensitive windows of susceptibility. The aim of this review was to summarize current evidence on the toxic effects of environment exposure during pregnancy, the neonatal period, and childhood. Alcohol use is related to foetal alcohol spectrum disorders, foetal alcohol syndrome being its most extreme form. Smoking is associated with placental abnormalities, preterm birth, stillbirth, or impaired growth and development, as well as with intellectual impairment, obesity, and cardiovascular diseases later in life. Negative birth outcomes have been linked to the use of drugs of abuse. Pregnant and lactating women are exposed to endocrine-disrupting chemicals and heavy metals present in foodstuffs, which may alter hormones in the body. Prenatal exposure to these compounds has been associated with pre-eclampsia and intrauterine growth restriction, preterm birth, and thyroid function. Metals can accumulate in the placenta, causing foetal growth restriction. Evidence on the effects of air pollutants on pregnancy is constantly growing, for example, preterm birth, foetal growth restriction, increased uterine vascular resistance, impaired placental vascularization, increased gestational diabetes, and reduced telomere length. The advantages of breastfeeding outweigh any risks from contaminants. However, it is important to assess health outcomes of toxic exposures via breastfeeding. Initial studies suggest an association between pre-eclampsia and environmental noise, particularly with early-onset pre-eclampsia. There is rising evidence of the negative effects of environmental contaminants following exposure during pregnancy and breastfeeding, which should be considered a major public health issue.

Identifiants

pubmed: 33735860
pii: 000514884
doi: 10.1159/000514884
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

245-257

Informations de copyright

© 2021 S. Karger AG, Basel.

Auteurs

M Dolores Gómez-Roig (MD)

BCNatal, Barcelona Centre for Maternal Foetal and Neonatal Medicine, Hospital Sant Joan de Déu and Hospital Clínic, Universitat de Barcelona, Barcelona, Spain.
Institut de Recerca Sant Joan de Déu (IR-SJD), Barcelona, Spain.

Rosalia Pascal (R)

BCNatal, Barcelona Centre for Maternal Foetal and Neonatal Medicine, Hospital Sant Joan de Déu and Hospital Clínic, Universitat de Barcelona, Barcelona, Spain, rpascal@sjdhospitalbarcelona.org.
Institut de Recerca Sant Joan de Déu (IR-SJD), Barcelona, Spain, rpascal@sjdhospitalbarcelona.org.

Marc Josep Cahuana (MJ)

BCNatal, Barcelona Centre for Maternal Foetal and Neonatal Medicine, Hospital Sant Joan de Déu and Hospital Clínic, Universitat de Barcelona, Barcelona, Spain.
Institut de Recerca Sant Joan de Déu (IR-SJD), Barcelona, Spain.

Oscar García-Algar (O)

BCNatal, Barcelona Centre for Maternal Foetal and Neonatal Medicine, Hospital Sant Joan de Déu and Hospital Clínic, Universitat de Barcelona, Barcelona, Spain.
Neonatology Unit, Hospital Clinic-Maternitat, ICGON, Universitat de Barcelona, Barcelona, Spain.

Giorgia Sebastiani (G)

BCNatal, Barcelona Centre for Maternal Foetal and Neonatal Medicine, Hospital Sant Joan de Déu and Hospital Clínic, Universitat de Barcelona, Barcelona, Spain.
Neonatology Unit, Hospital Clinic-Maternitat, ICGON, Universitat de Barcelona, Barcelona, Spain.

Vicente Andreu-Fernández (V)

Grup de Recerca Infancia i Entorn (GRIE), Institut d'investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
Valencian International University (VIU), Valencia, Spain.

Leopoldo Martínez (L)

Servicio de Cirugía Pediátrica, Hospital la Paz, Instituto de Investigación la Paz (IdiPAZ), Madrid, Spain.

Gerardo Rodríguez (G)

Growth, Exercise, Nutrition, and Development (GENUD) Research Group, Instituto de Investigación Sanitaria Aragón (IIS Aragón), Universidad de Zaragoza, Zaragoza, Spain.

Iris Iglesia (I)

Growth, Exercise, Nutrition, and Development (GENUD) Research Group, Instituto de Investigación Sanitaria Aragón (IIS Aragón), Universidad de Zaragoza, Zaragoza, Spain.

Olimpia Ortiz-Arrabal (O)

Department of Biochemistry and Molecular Biology II, Institute of Nutrition and Food Technology "José Mataix", Biomedical Research Center, University of Granada, Parque Tecnológico de la Salud, Granada, Spain.

María Dolores Mesa (MD)

Department of Biochemistry and Molecular Biology II, Institute of Nutrition and Food Technology "José Mataix", Biomedical Research Center, University of Granada, Parque Tecnológico de la Salud, Granada, Spain.
Ibs.Granada, Instituto de Investigación Biosanitaria, Complejo Hospitalario Universitario de Granada, Granada, Spain.

María Jesús Cabero (MJ)

Hospital Universitario Marqués de Valdecilla, Santander, Spain.

Lorenzo Guerra (L)

Hospital Universitario Marqués de Valdecilla, Santander, Spain.

Elisa Llurba (E)

Obstetrics and Gynaecology Department, High Risk Unit, Sant Pau University Hospital, Barcelona, Spain.
Women and Perinatal Health Research Group, Biomedical Research Institute Sant Pau (IIB-SantPau), Sant Pau University Hospital, Barcelona, Spain.
School of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain.

Carla Domínguez (C)

Obstetrics and Gynaecology Department, High Risk Unit, Sant Pau University Hospital, Barcelona, Spain.
Women and Perinatal Health Research Group, Biomedical Research Institute Sant Pau (IIB-SantPau), Sant Pau University Hospital, Barcelona, Spain.
School of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain.

Maria Julia Zanini (MJ)

Obstetrics and Gynaecology Department, High Risk Unit, Sant Pau University Hospital, Barcelona, Spain.
Women and Perinatal Health Research Group, Biomedical Research Institute Sant Pau (IIB-SantPau), Sant Pau University Hospital, Barcelona, Spain.
School of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain.

Maria Foraster (M)

ISGlobal, Barcelona Institute for Global Health, Barcelona, Spain.
Universitat Pompeu Fabra (UPF), Barcelona, Spain.
CIBER Epidemiología y Salud Pública (CIBERESO), Madrid, Spain.
Blanquerna School of Health Science, Universitat Ramon Llull, Barcelona, Spain.

Elvira Larqué (E)

Department of Physiology, Biomedical Institute of Research of Murcia Region (IMIB), Murcia University, Murcia, Spain.

Fernando Cabañas (F)

Department of Neonatology, Quironsalud Madrid University Hospital and Quironsalud San Jose Hospital, Madrid, Spain.
Biomedical Research Foundation-IDIPAZ, La Paz University Hospital, Madrid, Spain.

Manuela Lopez-Azorín (M)

Department of Neonatology, Quironsalud Madrid University Hospital and Quironsalud San Jose Hospital, Madrid, Spain.

Aitziber Pérez (A)

Neonatology Unit, University Hospital Cruces, Biocruces Bizkaia Health Research Institute, Barakaldo, Spain.

Begoña Loureiro (B)

Neonatology Unit, University Hospital Cruces, Biocruces Bizkaia Health Research Institute, Barakaldo, Spain.

Carmen Rosa Pallás-Alonso (CR)

Donated Milk Bank, Health Research Institute i + 12, University Hospital 12 de Octubre, Universidad Complutense, Madrid, Spain.

Diana Escuder-Vieco (D)

Donated Milk Bank, Health Research Institute i + 12, University Hospital 12 de Octubre, Universidad Complutense, Madrid, Spain.

Máximo Vento (M)

Neonatal Research Group, Health Research Institute La Fe, University and Polytechnic Hospital La Fe, Valencia, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH